Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.74
Delayed Data
As of Aug 25
 -0.02 / -0.72%
Today’s Change
2.58
Today|||52-Week Range
5.68
-22.60%
Year-to-Date
3 Horrible Stocks for Retirees
Aug 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.76
Today’s open2.76
Day’s range2.69 - 2.78
Volume1,044,199
Average volume (3 months)1,383,616
Market cap$456.9M
Dividend yield7.30%
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio1.9
Price/Sales0.99
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.04-0.61%
OMEROmeros Corp0.000.00%
CXRXConcordia Internatio...+0.02+0.22%
ARDXArdelyx Inc+0.45+4.68%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers

Search for Jobs